Skip to main content

Effects of silencing the DUSP1 gene using lentiviral vector-mediated siRNA on the release of proinflammatory cytokines through regulation of the MAPK signaling pathway in mice with acute pancreatitis

Buy Article:

$42.00 + tax (Refund Policy)

The present study investigated the effects of dual specificity phosphatase 1 (DUSP1) gene silencing using lentiviral vector-mediated small interfering (si)RNA on the release of proinflammatory cytokines through the regulation of the mitogenactivated protein kinase (MAPK) signaling pathway in mice with acute pancreatitis (AP). Two siRNADUSP1 sequences and one scramble siRNA sequence were designed, and the expression of DUSP1 was detected using western blot analysis to screen for the one with a higher interference rate. An AP mouse model was established, and KM mice were assigned to either a control, siRNA, AP, AP+PD98059, AP+scramble, AP+siRNA or AP+PD98059+siRNA group. The expression of proinflammatory cytokines, including tumor necrosis factor (TNF)α, interleukin (IL)1β and IL6, high mobility group box 1 (HMGB1), and S100A12 in serum samples were detected using an enzymelinked immunosorbent assay at 12, 24 and 48 h postmodeling. The serum amylase levels were also detected. The expression levels of DUSP1, TNFα, IL1β, IL6, HMGB1, S100A12, phosphorylated (p) extracellular signalregulated kinase (ERK), pcJun Nterminal kinase (JNK), pp38, ERK, JNK and p38 in pancreatic, liver, kidney and lung tissues were detected using reverse transcriptionquantitative polymerase chain reaction and western blot analysis. Compared with the control group, the siRNA group demonstrated marginally upregulated serum amylase, lipase, urinary trypsinogen2, and proinflammatory cytokines, HMGB1 and S100A12 in serum and tissues, with no statistically significant difference, elevated expression levels of pERK, pJNK and pp38, and decreased expression of DUSP1. The other five groups demonstrated increased expression levels of TNFα, IL1β, IL6, HMGB1, S100A12, amylase, lipase and urinary trypsinogen2 in serum, and increased expression levels of DUSP1, TNFα, IL1β, IL6, HMGB1, S100A12, pERK, pJNK and pp38 in tissues. Compared with the AP group, the AP+PD98059+siRNA group had decreased expression of DUSP1 in tissues, whereas the AP+PD98059 group had decreased serum expression levels of TNFα, IL1β, IL6, HMGB1, S100A12 and amylase, lipase and urinary trypsinogen2. The expression levels of TNFα, IL1β, IL6, HMGB1, S100A12, pERK, pJNK, pp38 in tissues, and edema of pancreatic tissue were alleviated, whereas the opposite results were observed in the AP+siRNA group with the decreased expression of DUSP1. The results suggested that DUSP1 gene silencing promoted the release of proinflammatory cytokines through activation of the MAPK signaling pathway in mice with AP.

Document Type: Research Article

Affiliations: 1: Department of Hepatobiliary Surgery, Qianfoshan Hospital, Shandong University, Jinan, Shandong 250014, P.R. China 2: Department of General Surgery, The Second People's Hospital of Liaocheng, Liaocheng, Shandong 252600, P.R. China 3: Department of Emergency, The Second People's Hospital of Liaocheng, Liaocheng, Shandong 252600, P.R. China

Publication date: 01 January 2018

More about this publication?
  • The International Journal of Molecular Medicine is a monthly, peer-reviewed journal devoted to the publication of high quality studies related to the molecular mechanisms of human disease. The journal welcomes research on all aspects of molecular and clinical research, ranging from biochemistry to immunology, pathology, genetics, human genomics, microbiology, molecular pathogenesis, molecular cardiology, molecular surgery and molecular psychology.

    The International Journal of Molecular Medicine aims to provide an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content